Եվրոպական Միություն -
սլովեներեն -
EMA (European Medicines Agency)
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - druga zdravila na živčnem sistemu - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
Եվրոպական Միություն -
սլովեներեն -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Եվրոպական Միություն -
սլովեներեն -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - zavrnitev nevromuskularne blokade, ki jo inducira rocuronium ali vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Սլովենիա -
սլովեներեն -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
sugamadeks sandoz 100 mg/ml raztopina za injiciranje
sugamadeks - raztopina za injiciranje - sugamadeks 100 mg / 1 ml - sugamadeks
Եվրոպական Միություն -
սլովեներեն -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskularna blokada - sugamadeks - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Եվրոպական Միություն -
սլովեներեն -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Եվրոպական Միություն -
սլովեներեն -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Եվրոպական Միություն -
սլովեներեն -
EMA (European Medicines Agency)
bridion
merck sharp & dohme b.v. - sugamadeks - neuromuskularna blokada - vsi drugi terapevtski izdelki - zavrnitev nevromuskularne blokade, ki jo inducira rocuronium ali vecuronium. za peadiatric prebivalstva: sugammadex je priporočena le za rutinsko odprave rokuronij zaradi blokade pri otrocih in mladostnikih.
Եվրոպական Միություն -
սլովեներեն -
EMA (European Medicines Agency)
memantine mylan
mylan pharmaceuticals limited - memantinijev klorid - alzheimerjeva bolezen - other anti-dementia drugs, psychoanaleptics, - zdravljenje bolnikov z zmerno do hudo alzheimerjevo boleznijo.
Եվրոպական Միություն -
սլովեներեն -
EMA (European Medicines Agency)
olanzapine mylan
mylan pharmaceuticals limited - olanzapin - schizophrenia; bipolar disorder - psiholeptiki - adultsolanzapine je primerna za zdravljenje shizofrenije. olanzapin je učinkovita pri ohranjanju klinično izboljšanje, med nadaljevanje terapije pri bolnikih, ki so pokazali začetni odziv zdravljenje. olanzapin je primerna za zdravljenje zmerno do hudo manične epizode. pri bolnikih, katerih manične epizode se je odzvala na olanzapin zdravljenje, olanzapin, je indicirano za preprečevanje ponovitve pri bolnikih z bipolarno motnjo.